DHG Pharmaceutical JSC (DHG) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.107x

Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) has a cash flow conversion efficiency ratio of 0.107x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫447.50 Billion ≈ $17.00 Million USD) by net assets (₫4.18 Trillion ≈ $158.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of DHG Pharmaceutical JSC to measure how much of total assets are equity-financed.

DHG Pharmaceutical JSC - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how DHG Pharmaceutical JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of DHG Pharmaceutical JSC to evaluate the quality of earnings relative to operating cash generation.

DHG Pharmaceutical JSC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DHG Pharmaceutical JSC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Guangdian Electric Group Co Ltd SHG:601616	-0.002x
ChoiceOne Financial Services Inc NASDAQ:COFS	0.030x
Tengda Construction Group Co Ltd SHG:600512	-0.002x
Aquestive Therapeutics Inc NASDAQ:AQST	0.435x
Compania General de Electricidad SA SN:CGE	-0.004x
Ari Real Estate Arena Investment Ltd TA:ARIN	0.014x
EUROKAI GmbH & Co. KGaA F:EUK3	0.017x
Ranpak Holdings Corp NYSE:PACK	0.008x

Annual Cash Flow Conversion Efficiency for DHG Pharmaceutical JSC (2019–2025)

The table below shows the annual cash flow conversion efficiency of DHG Pharmaceutical JSC from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see DHG company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫4.18 Trillion ≈ $158.91 Million	₫1.22 Trillion ≈ $46.51 Million	0.293x	-9.05%
2024-12-31	₫4.09 Trillion ≈ $155.58 Million	₫1.32 Trillion ≈ $50.06 Million	0.322x	+457.94%
2023-12-31	₫4.85 Trillion ≈ $184.38 Million	₫279.88 Billion ≈ $10.63 Million	0.058x	-72.54%
2022-12-31	₫4.29 Trillion ≈ $163.05 Million	₫901.28 Billion ≈ $34.24 Million	0.210x	+76.07%
2021-12-31	₫3.79 Trillion ≈ $144.12 Million	₫452.44 Billion ≈ $17.19 Million	0.119x	-48.49%
2020-12-31	₫3.57 Trillion ≈ $135.56 Million	₫826.17 Billion ≈ $31.39 Million	0.232x	-6.70%
2019-12-31	₫3.38 Trillion ≈ $128.33 Million	₫838.24 Billion ≈ $31.85 Million	0.248x	--

About DHG Pharmaceutical JSC

VN:DHG Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$470.92 Million

₫12.39 Trillion VND

Market Cap Rank

#12532 Global

#57 in Vietnam

Share Price

₫94800.00

Change (1 day)

+1.39%

52-Week Range

₫90200.00 - ₫108100.00

All Time High

₫130801.51